Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073294
Status:
WITHDRAWN
Last Update Posted:
2018-03-02
First Post:
2003-11-18
Brief Title:
Insulin Resistance and Insulin Secretion
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Study Overview
Official Title:
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status:
WITHDRAWN
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Trial was not funded
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a pilot study to examine the prevalence of metabolic risk factors impaired insulin release and impaired insulin sensitivity for type 2 diabetes mellitus in children and adults from a population that is at high risk for this disease We hypothesize that at least one of these pre-diabetic traits will be evident in a large proportion of relatives of known type 2 diabetic children as compared to a control group of subjects without a family history of type 2 diabetes By isolating these traits it will be possible to determine the relative contributions of genes and environment to each trait and to identify those at risk for subsequent development of type 2 diabetes by virtue of having one trait Ultimately those individuals at risk especially those with impaired insulin release would hopefully benefit from intervention to prevent the weight gain that will unmask their underlying pancreatic dysfunction and thus prevent or retard the development of type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None